Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2021 / Sep / ESCRS 2021: An Invite from Glaukos
Sponsored

ESCRS 2021: An Invite from Glaukos

Andrew Geddes, Vice President, Commercial – Europe, Middle East & India at Glaukos, talks about the company's plans for this year's ESCRS Meeting

Sponsored By Glaukos 9/8/2021 1 min read

Share

The ESCRS Meeting is a great opportunity for all attendees – both in person and virtual – to learn how iStent inject® W helps improve patients’ quality of life by reducing or eliminating the need for medications – both decreasing IOP and improving ocular surface outcomes.

Additionally, we will show how iLinkTM V can slow or halt keratoconus when patients are treated with the KXL® System using VibeX® Rapid riboflavin. We will have our specialist team available to meet you at our booth in a safety-conscious environment.

Our dual lunchtime interactive symposia enable surgeons to attend both days’ seminars and benefit from the experience of international speakers specializing in mild to moderate glaucoma and CXL treatment.

Surgeons visiting the Glaukos booth will learn about our latest technologies for their mild to moderate glaucoma surgical options, and how to best improve their keratoconic patients’ quality of life through our KXL® treatment options combined with our Vibex® product range.

Booth Number A23

Symposia: Preserve your Patients’ Quality of Life with iStent inject® W Trabecular Micro- Bypass, October 9, 11:45 to 12:45pm

Transforming the Standard of Care for Keratoconus with iLinkTM V, October 10, 11.45 am-12.45 pm.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: